Diebold Nixdorf, Incorporated
DBD
$61.70
$1.692.82%
NYSE
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 945.20M | 915.20M | 841.10M | 988.90M | 927.10M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 945.20M | 915.20M | 841.10M | 988.90M | 927.10M |
| Cost of Revenue | 697.30M | 672.50M | 627.90M | 752.50M | 685.30M |
| Gross Profit | 247.90M | 242.70M | 213.20M | 236.40M | 241.80M |
| SG&A Expenses | 141.00M | 147.90M | 145.00M | 126.00M | 139.20M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | 100.00K | 100.00K | -1.70M | -1.00M | 1.50M |
| Total Operating Expenses | 858.80M | 842.70M | 791.50M | 899.80M | 848.90M |
| Operating Income | 86.40M | 72.50M | 49.60M | 89.10M | 78.20M |
| Income Before Tax | 51.30M | 17.50M | -9.70M | 11.90M | 8.20M |
| Income Tax Expenses | 9.60M | 4.80M | -2.20M | 5.50M | 29.90M |
| Earnings from Continuing Operations | 41.70M | 12.70M | -7.50M | 6.40M | -21.70M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -600.00K | -500.00K | -800.00K | -800.00K | -700.00K |
| Net Income | 41.10M | 12.20M | -8.30M | 5.60M | -22.40M |
| EBIT | 86.40M | 72.50M | 49.60M | 89.10M | 78.20M |
| EBITDA | 118.10M | 103.70M | 83.50M | 132.40M | 108.80M |
| EPS Basic | 1.13 | 0.33 | -0.22 | 0.15 | -0.60 |
| Normalized Basic EPS | 1.08 | 0.55 | 0.15 | 0.77 | 0.65 |
| EPS Diluted | 1.11 | 0.33 | -0.22 | 0.15 | -0.60 |
| Normalized Diluted EPS | 1.06 | 0.55 | 0.15 | 0.77 | 0.65 |
| Average Basic Shares Outstanding | 36.50M | 37.20M | 37.60M | 37.60M | 37.60M |
| Average Diluted Shares Outstanding | 37.00M | 37.50M | 37.60M | 37.60M | 37.60M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |